ENDRA Life Sciences (NDRA) Reports In-Line Q2 EPS

ENDRA Life Sciences (NASDAQ: NDRA) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Microchip Technology to acquire edge AI chip firm Hailo
• Charter Communications (CHTR) Tops Q2 EPS by 66c